Cadaverine Tartrate

Cadaverine Tartrate

SCHEMBL4254570

CCCCCCCC/C=C\CCCCCCCCOC(=O)CN1CCNCC1.O=C(O)C(O)C(O)C(=O)O

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3CHRM1CHRM2CHRM3CHRM4ESR1ESR2GABRA1GABRB1GABRG2GBA1HRH1HTR1DHTR2AOPRD1OPRK1OPRM1SLC6A2SLC6A3TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8rplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Cadaverine Tartrate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
FAAH O00519 1/20 0.44
EPHX2 P34913 2/20 0.41
P2RY10 O00398 4/20 0.39
GPR34 Q9UPC5 1/20 0.39
ALDH1A1 P00352 1/20 0.39
MAPT P10636 1/20 0.39
THRB P10828 1/20 0.39
CNR1 P21554 1/20 0.39
DGKA P23743 1/20 0.39
NAAA Q02083 1/20 0.38
MGLL Q99685 1/20 0.38
SIGMAR1 Q99720 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4264512 0.92 FAAH (0.51) FAAHEPHX2ALDH1A1MAPTTHRB
Cadaverine Tartrate SCHEMBL5987469 0.88 FAAH (0.45) FAAHEPHX2P2RY10GPR34ALDH1A1
Cadaverine Tartrate SCHEMBL5986724 0.80 THRA (0.44) FAAHALDH1A1MAPTTHRBDGKA
SCHEMBL2323553 0.79 SIGMAR1 (0.51) ALDH1A1MAPTNAAASIGMAR1
SCHEMBL3669028 0.79 SIGMAR1 (0.51) ALDH1A1MAPTNAAASIGMAR1
SCHEMBL5990174 0.78 FAAH (0.52) FAAHEPHX2ALDH1A1MAPTTHRB
SCHEMBL27907907 0.78 FAAH (0.48) FAAHEPHX2MAPT
SCHEMBL5724530 0.78 SIGMAR1 (0.50) ALDH1A1NAAASIGMAR1
SCHEMBL163676 0.76 FAAH (0.51) FAAHEPHX2MAPT
SCHEMBL163678 0.76 FAAH (0.51) FAAHEPHX2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8987263-B2 Basic esters of fatty alcohols and their use as anti-inflammatory or immunomodulatory agents YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2015-03-24 US claimed
EP-2117301-A1 USE OF LONG-CHAIN ALCOHOL DERIVATIVES FOR THE TREATMENT OF ALOPECIA AREATA Yeda Research And Development Co. Ltd. At The Weizmann Institute of Science (IL) 2009-11-18 EP claimed
US-20080221115-A1 Use of long-chain alcohol derivatives for the treatment of alopecia areata YEDA RESEARCH AND DEVELOPMENT CO. (IL) 2008-09-11 US claimed
WO-2008106091-A1 USE OF LONG-CHAIN ALCOHOL DERIVATIVES FOR THE TREATMENT OF ALOPECIA AREATA YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2008-09-04 WO claimed
US-20060173053-A1 Basic esters of fatty alcohols and their use as anti-inflammatory or immunomodulatory agents YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2006-08-03 US claimed
EP-1551495-A2 BASIC ESTERS OF FATTY ALCOHOLS AND THEIR USE AS ANTI-INFLAMMATORY OR IMMUNOMODULATORY AGENTS YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2005-07-13 EP claimed
WO-2004032824-A2 BASIC ESTERS OF FATTY ALCOHOLS AND THEIR USE AS ANTI-INFLAMMATORY OR IMMUNOMODULATORY AGENTS YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2004-04-22 WO claimed
US-8987263-B2 Basic esters of fatty alcohols and their use as anti-inflammatory or immunomodulatory agents YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2015-03-24 US disclosed
EP-2117301-A1 USE OF LONG-CHAIN ALCOHOL DERIVATIVES FOR THE TREATMENT OF ALOPECIA AREATA Yeda Research And Development Co. Ltd. At The Weizmann Institute of Science (IL) 2009-11-18 EP disclosed
US-20080221115-A1 Use of long-chain alcohol derivatives for the treatment of alopecia areata YEDA RESEARCH AND DEVELOPMENT CO. (IL) 2008-09-11 US disclosed
WO-2008106091-A1 USE OF LONG-CHAIN ALCOHOL DERIVATIVES FOR THE TREATMENT OF ALOPECIA AREATA YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2008-09-04 WO disclosed
US-20060173053-A1 Basic esters of fatty alcohols and their use as anti-inflammatory or immunomodulatory agents YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2006-08-03 US disclosed
EP-1551495-A2 BASIC ESTERS OF FATTY ALCOHOLS AND THEIR USE AS ANTI-INFLAMMATORY OR IMMUNOMODULATORY AGENTS YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2005-07-13 EP disclosed
WO-2004032824-A2 BASIC ESTERS OF FATTY ALCOHOLS AND THEIR USE AS ANTI-INFLAMMATORY OR IMMUNOMODULATORY AGENTS YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2004-04-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080221115-A1 Use of long-chain alcohol derivatives for the treatment of alopecia areata SLC38A7, CCR8, ADH1A FAAH 646/4885EPHX2 3591/4885P2RY10 4406/4885
US-20060173053-A1 Basic esters of fatty alcohols and their use as anti-inflammatory or immunomodulatory agents ALOX12, ALOX15, ALOX15B FAAH 117/4885EPHX2 561/4885P2RY10 2481/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.